October 1st, 2010
Podcast 103: eGFR and cardiovascular risk assessment
Podcast: Play in new window | Download
Subscribe: RSS
Welcome back. We take a look this week at a study from Iceland that looks at whether estimated glomerular filtration rates have a role in estimating cardiovascular risk. Our interview is with Cambridge University’s Dr. Emanuele Di Angelantonio.
Your comments are welcome, both here and to my email address: jelia@jwatch.org.
Interview-related links:
- BMJ study (free)
- BMJ meta-analysis (free)
- BMJ editorial (subscription needed)
News-related links:
- ADHD story in Physician’s First Watch
- Archives of Disease in Childhood (abstract)
- MMWR (free)
- Annals of Family Medicine (free full text)
One Response to “Podcast 103: eGFR and cardiovascular risk assessment”
About the Podcast
Comments, suggestions, and story ideas welcome. Learn more about Clinical Conversations.
Follow us:
GFR and decline in renal function can be improved by cardiovascular prevention.The series and pathology studies of Abboud H et al described the prevalence of nephroangiosclerosis in 820 necroptic samples in neurologic patients.
The OR for NAS , adjusted for age and sex , was 4.37 and 2.94 after consideration for CV risk factors . Thus , was independently associated with age and history of hypertension in patients with stroke , comparable to SPARCL results ( statin treatment with stroke or TIA improvement GFR).